Olwen Hahn to Neoplasm, Residual
This is a "connection" page, showing publications Olwen Hahn has written about Neoplasm, Residual.
Connection Strength
0.046
-
CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer. J Clin Oncol. 2022 04 20; 40(12):1323-1334.
Score: 0.046